CTM_ Trademark

Trademark Overview


On Wednesday, February 14, 2024, a trademark application was filed for CTM_ with the United States Patent and Trademark Office. The USPTO has given the CTM_ trademark a serial number of 98406015. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Friday, April 11, 2025. This trademark is owned by CTM Biomedical, LLC. The CTM_ trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
ctm_

General Information


Serial Number98406015
Word MarkCTM_
Filing DateWednesday, February 14, 2024
Status645 - FINAL REFUSAL - MAILED
Status DateFriday, April 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHuman allograft tissue
In Another Form StatementThe mark was first used in commerce in a different form other than that sought to be registered at least as early as 09/00/2019.
In Another Form StatementThe mark was first used anywhere in a different form other than that sought to be registered at least as early as 09/00/2019.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 14, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCTM Biomedical, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33130

Trademark Events


Event DateEvent Description
Wednesday, February 14, 2024NEW APPLICATION ENTERED
Monday, June 17, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 6, 2024ASSIGNED TO EXAMINER
Wednesday, September 11, 2024NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2024NON-FINAL ACTION E-MAILED
Wednesday, September 11, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 11, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 11, 2025FINAL REFUSAL WRITTEN
Friday, April 11, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, April 11, 2025FINAL REFUSAL E-MAILED
Wednesday, December 11, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, December 11, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Related Keywords


tissue allograft human